ANAPTYSBIO, INC — Director's Dealing 2017

Aug 9, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAPTYSBIO INC (ANAB)
CIK: 0001370053
Period of Report: 2017-08-04

Reporting Person: Novo Holdings A/S (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-04	Common Stock	S	10271	$22.0001	Disposed	2952527	Direct
2017-08-07	Common Stock	S	480000	$21.10	Disposed	2472527	Direct
2017-08-07	Common Stock	S	1023	$22.9155	Disposed	2471504	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in two transactions with one transaction pricing at $22.00 and the other transaction pricing at $22.01. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.76 to $23.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.